RESULTS OF A PHASE III TRIAL IN PATIENTS WITH PIDD USING AN IVIG CONTAINING HIGH TITER NEUTRALIZING ANTIBODY TO RESPIRATORY SYNCYTIAL VIRUS ( RSV)